133 related articles for article (PubMed ID: 19108654)
1. Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation.
Trunzer M; Faller B; Zimmerlin A
J Med Chem; 2009 Jan; 52(2):329-35. PubMed ID: 19108654
[TBL] [Abstract][Full Text] [Related]
2. Utility of MetaSite in improving metabolic stability of the neutral indomethacin amide derivative and selective cyclooxygenase-2 inhibitor 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-phenethyl-acetamide.
Boyer D; Bauman JN; Walker DP; Kapinos B; Karki K; Kalgutkar AS
Drug Metab Dispos; 2009 May; 37(5):999-1008. PubMed ID: 19196840
[TBL] [Abstract][Full Text] [Related]
3. A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen.
Kieltyka K; Zhang J; Li S; Vath M; Baglieri C; Ferraro C; Zvyaga TA; Drexler DM; Weller HN; Shou WZ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1579-91. PubMed ID: 19399765
[TBL] [Abstract][Full Text] [Related]
4. Development, optimization and implementation of a centralized metabolic soft spot assay.
Paiva AA; Klakouski C; Li S; Johnson BM; Shu YZ; Josephs J; Zvyaga T; Zamora I; Shou WZ
Bioanalysis; 2017 Apr; 9(7):541-552. PubMed ID: 28339283
[TBL] [Abstract][Full Text] [Related]
5. Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates.
Di L; Kerns EH; Hong Y; Kleintop TA; McConnell OJ; Huryn DM
J Biomol Screen; 2003 Aug; 8(4):453-62. PubMed ID: 14567798
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Metabolic Soft-Spot Identification in Liver Microsomes by LC/UV/MS: Application of a Single Variable Incubation Time Approach.
Zhu Y; Chen G; Zhang K; Chen C; Chen W; Zhu M; Jiang H
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432161
[TBL] [Abstract][Full Text] [Related]
7. Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the series.
Ceccarelli SM; Schlotterbeck G; Boissin P; Binder M; Buettelmann B; Hanlon S; Jaeschke G; Kolczewski S; Kupfer E; Peters JU; Porter RH; Prinssen EP; Rueher M; Ruf I; Spooren W; Stämpfli A; Vieira E
ChemMedChem; 2008 Jan; 3(1):136-44. PubMed ID: 17994660
[TBL] [Abstract][Full Text] [Related]
8. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects.
Van Eeckhaut A; Lanckmans K; Sarre S; Smolders I; Michotte Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2198-207. PubMed ID: 19179125
[TBL] [Abstract][Full Text] [Related]
9. High throughput metabolic stability screen for lead optimization in drug discovery.
Tong XS; Xu S; Zheng S; Pivnichny JV; Martin J; Dufresne C
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 833(2):165-73. PubMed ID: 16504609
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic theory of cassette dosing in drug discovery screening.
White RE; Manitpisitkul P
Drug Metab Dispos; 2001 Jul; 29(7):957-66. PubMed ID: 11408361
[TBL] [Abstract][Full Text] [Related]
11. False-positive liquid chromatography/tandem mass spectrometric confirmation of sebuthylazine residues using the identification points system according to EU directive 2002/657/EC due to a biogenic insecticide in tarragon.
Schürmann A; Dvorak V; Crüzer C; Butcher P; Kaufmann A
Rapid Commun Mass Spectrom; 2009 Apr; 23(8):1196-200. PubMed ID: 19288539
[TBL] [Abstract][Full Text] [Related]
12. Overview of strategies for addressing BRIs in drug discovery: Impact on optimization and design.
Humphreys WG
Chem Biol Interact; 2011 Jun; 192(1-2):56-9. PubMed ID: 21238435
[TBL] [Abstract][Full Text] [Related]
13. Software automation tools for increased throughput metabolic soft-spot identification in early drug discovery.
Zelesky V; Schneider R; Janiszewski J; Zamora I; Ferguson J; Troutman M
Bioanalysis; 2013 May; 5(10):1165-79. PubMed ID: 23721441
[TBL] [Abstract][Full Text] [Related]
14. Accurate-mass databases for comprehensive screening of pesticide residues in food by fast liquid chromatography time-of-flight mass spectrometry.
Mezcua M; Malato O; García-Reyes JF; Molina-Díaz A; Fernández-Alba AR
Anal Chem; 2009 Feb; 81(3):913-29. PubMed ID: 19117389
[TBL] [Abstract][Full Text] [Related]
15. Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.
Li AC; Ding J; Jiang X; Denissen J
Rapid Commun Mass Spectrom; 2009 Sep; 23(18):3003-12. PubMed ID: 19681099
[TBL] [Abstract][Full Text] [Related]
16. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist.
Cruciani G; Carosati E; De Boeck B; Ethirajulu K; Mackie C; Howe T; Vianello R
J Med Chem; 2005 Nov; 48(22):6970-9. PubMed ID: 16250655
[TBL] [Abstract][Full Text] [Related]
17. Importance of using highly pure internal standards for successful liquid chromatography/tandem mass spectrometric bioanalytical assays.
Bergeron A; Furtado M; Garofolo F
Rapid Commun Mass Spectrom; 2009 May; 23(9):1287-97. PubMed ID: 19308966
[TBL] [Abstract][Full Text] [Related]
18. Application of LC/MS and related techniques to high-throughput drug discovery.
Espada A; Molina-Martin M; Dage J; Kuo MS
Drug Discov Today; 2008 May; 13(9-10):417-23. PubMed ID: 18468559
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel in vitro metabonate from liver microsomal incubations.
Li C; Surapaneni S; Zeng Q; Marquez B; Chow D; Kumar G
Drug Metab Dispos; 2006 Jun; 34(6):901-5. PubMed ID: 16554371
[TBL] [Abstract][Full Text] [Related]
20. Identification of metabolites of meisoindigo in rat, pig and human liver microsomes by UFLC-MS/MS.
Huang M; Ho PC
Biochem Pharmacol; 2009 Apr; 77(8):1418-28. PubMed ID: 19426681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
